Expression systems for production of recombinant proteins in bacteria

Projektinformationen

EXPRESS

ID Finanzhilfevereinbarung: QLK3-CT-2001-60017

Startdatum 7 Juni 2002

Enddatum 6 Juni 2004

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 112 584,00

EU-Beitrag € 112 584,00

Koordiniert durch

BIOVITRUM AB
Sweden

Ziel

The research deals with evaluation of novel expression strategies for production of protein-based pharmaceuticals as soluble proteins in Escherichia coil in high cell density cultivations.

Wissenschaftliches Gebiet

• natural sciences › biological sciences › microbiology › bacteriology
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• natural sciences › biological sciences › biochemistry › biomolecules › proteins

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-3. - Key action The "Cell factory"

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

BUR - Bursaries, grants, fellowships

Koordinator

BIOVITRUM AB

• EU-Beitrag: Keine Daten
• Adresse: Lindhagensgatan 133 ; SE-112 76 STOCKHOLM ; Schweden
• Gesamtkosten: Keine Daten